noom reviews glp 1 Microdosing GLP-1 for Weight Loss Noom jumps into off-brand weight
Description
In clinical trials, the GLP1 in the brand name wegovy, has been found to lead to significant weight loss compared to placebo, as well as improve several metabolic markers such as blood pressure, lipid levels, and insulin resistance
These agents act on GLP-1Rs distributed in pancreatic, gastrointestinal, cardiovascular, hepatic, and neural tissues, mediating both peripheral and central effects
Platforms like Joi + Blokes operate within this telehealth model, connecting patients with independent clinicians who evaluate eligibility remotely
This distinction defines what microdosing can and cannot reasonably be expected to accomplish
Gradual increments: After four weeks, its typical to experience a dose escalation
